MECHANISM OF ACTION
CJC-1295 is a modified version of the signal your brain normally sends to the pituitary gland (a pea-sized gland at the base of the brain) telling it to release growth hormone. The natural signal only lasts about 30 minutes before it breaks down. CJC-1295 is engineered to grab onto albumin (a common protein in your blood) once injected, which protects it from breaking down. This extends its activity from 30 minutes to roughly 6–8 days per injection. Your pituitary then releases growth hormone in pulses, the same natural pattern, raising both growth hormone and IGF-1 (a growth factor that supports muscle and recovery). Unlike injecting growth hormone directly, this keeps the body's own feedback system intact.
RESEARCH APPLICATIONS
- GH secretagogue research and pituitary axis modelling
- Body composition - lean mass accretion and adipose reduction
- IGF-1 axis stimulation research
- Age-related GH decline (somatopause) models
- Synergistic stacks with GHRP agents (Ipamorelin)
RESEARCH HIGHLIGHTS
Extended GH and IGF-1 Elevation
2006Research reported that a single administration produced an extended growth hormone peak lasting several days, with proportional IGF-1 increases.
Ref: Teichman et al., JCEM
Sustained IGF-1 Response
2009Twice-weekly administration maintained IGF-1 elevation above baseline for 14+ days with no tachyphylaxis over 6-week study periods.
Ref: Ionescu et al., Growth Horm IGF Res
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
Lyophilised: 2–8°C or -20°C. Reconstituted: 2–8°C, 21–28 days. Avoid room temperature.
Regulatory Status
No regulatory approval. WADA prohibited (S2). SAHPRA: import authorisation required for research.
Important - read before proceeding
This page is a summary of published scientific literature about a molecule. It is provided for research and educational purposes only. Nothing on this page is medical advice, a diagnosis, a recommendation, a prescription, or a claim that this compound treats, cures, prevents or improves any condition in humans. Research findings described here are observations reported by third-party researchers about the molecule - they are not statements about the product supplied by Bio Intelligence, and they should not be read as an expected outcome.
Compounds supplied are not registered medicines, have not been evaluated by SAHPRA, and are not for human consumption. No dosing, route of administration or usage guidance is provided by Bio Intelligence. If you have a health concern, speak to a registered healthcare practitioner.